FDA Inspection 1022647 — Sanjeet S. Dadwal
The FDA completed an inspection of Sanjeet S. Dadwal on Aug 8, 2017 in Duarte, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 8, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Duarte, CA (United States)
Additional details
Clinical Investigator (CI)